Here, we report that immunogenic chemotherapy-treated lung cancer cells exhibited an immunogenic senescence phenotype and had high expression of LUNX on their plasma membrane, which served as a targetable immunogenic antigen. The gene discussed is BPIFA1; the disease is lung carcinoma.